NASDAQ Capital Market•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Medicus Pharma unveils ex-GSK and Pfizer senior as chief medical officer
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
Medicus Pharma makes debut on Nasdaq raising $4M to advance skin cancer trial - ICYMI
Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States
Medicus Pharma announces pricing of US IPO
Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States
Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing
Medicus Pharma Ltd. Announces First Patient Randomized in Phase 2 Trial of SKNJCT-003 for the Treatment of Nodular Basal Cell Carcinoma in Adults
Medicus Pharma Ltd. Submits Updated Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin
Medicus Pharma Ltd. Announces Closing of Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes
Medicus Pharma Ltd. Announces Proposed Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes
Medicus Pharma Ltd. Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.